Searched for
NPPA
India raises price cap on cancer drugs to tackle shortageIndia's drug price regulator has increased the ceiling prices of cancer drugs cisplatin and carboplatin by 50% to tackle shortages caused b...- Cancer drug prices raised 50% as NPPA acts on shortage concernsIndia's drug pricing authority has approved a 50% price hike for essential anti-cancer drugs carboplatin and cisplatin. This decision follo...
- Government may lift price cap on cancer drugs making them costlier by up to 50%India's government is taking emergency steps to ensure cancer patients get vital drugs. Cisplatin and carboplatin, crucial chemotherapy age...
- Regulator, cos discuss price hike for some cancer drugsIndia's drug pricing authority may soon approve a price hike for vital platinum-based cancer medicines. These drugs, including carboplatin ...
- Good news for diabetes & BP patients: Govt cuts prices of these 30 medicines, relief may reach pharmacies soonThe National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 30 essential drug formulations, including those for diabet...
- No regular chief secretary for now, IAS officer K K Pant given additional chargeSenior IAS officer Kamlesh Kumar Pant has been given the additional charge of Chief Secretary in Himachal Pradesh. He currently holds posit...
- Out-of-pocket expenditure share declines by 21 percentage points from 2013-14: Health ministryGovernment health spending has risen, leading to a significant drop in out-of-pocket health expenses. This decline, from 64.2% in 2013-14 t...
- Drug regulator oversight sought for nutraceuticals; NGO flags quality, pricing concernsA Gujarat NGO is pushing the government to regulate nutraceuticals like medicines. They cite concerns about product quality and unregulated...
- Paracetamol may get costlier as Vizag chemists warn 30–40% drug cost surge amid Iran war-led pharma cost shockThe ongoing conflict in Iran is impacting India's healthcare sector. Pharmaceutical distributors warn of significant price increases for es...
- FOPE urges pause on NPPA notice, citing potential losses for pharma industryFOPE said that the manufactures follow the rules as laid down in the DPCO, 2013. At the same time, manufacturers look to NPPA to fix the pr...
- The tightrope walk of India's drug-price regulatorET Online retraces here the tenures of NPPA chiefs. The question to ask: Is taking on the pharma and healthcare lobby injurious to the NPPA...
- Private hospitals making up to 1,737% profit on drugs, finds NPPA studyNPPA's study found that "the major beneficiaries of profits in all these cases because of inflated MRPs have been hospitals rather than dru...
- NPPA fixes retail price of 30 drug formulationsThe National Pharmaceutical Pricing Authority (NPPA) has also revised the prices of three formulations, including that of anti cancer drug ...
- No plans to revamp NPPA: GovernmentIn a written reply to a question in the Rajya Sabha, Minister of State for Chemicals and Fertilisers Mansukh L Mandaviya said the governmen...
- NPPA may lose absolute power to fix drug prices under new policyNPPA presently functions as an autonomous body that regulates prices of medicines under National List of Essential Medicines and monitors p...
- Hospitals can't refuse to sell patients the stents they demand: NPPAIn case of non-compliance of NPPA's instructions, the regulator said it may be constrained to invoke provisions of legal prosecution under ...
- Pharma industry faults NPPA's latest move to cut drug pricesNPPA, on its part, has asserted that it would stand its ground should the issue go to court as its notification is correct as per law and u...
- Drug price regulator NPPA seeks to recover Rs 4,551 crore for overchargingNPPA is trying to recover a whopping Rs 4,551 crore, including interest, from various pharma companies for overcharging as of February this...
- Prices of around 12,000 drug SKUs decline in January: NPPAPrices of around 12,000 stock keeping units (SKUs) of medicines have come down during January this year as a consequence of implementation ...
- NPPA asked to revisit decision on prices for insulin: Srikant Kumar JenaThe DoP has asked NPPA to revisit the decision of fixing ceiling prices of various insulin formulations in the wake of review applications ...
Load More
